State Street Corp Zentalis Pharmaceuticals, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 1,246,613 shares of ZNTL stock, worth $4.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,246,613

Previous 3,052,392 59.16%

Holding current value

$4.19 Million

Previous $12.5 Million 63.35%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.9 - $4.57 $5.24 Million - $8.25 Million	-1,805,779 Reduced 59.16%	1,246,613 $4.58 Million
Q2 2024 Aug 14, 2024	SELL	$4.09 - $16.13 $3 Million - $11.8 Million	-733,260 Reduced 19.37%	3,052,392 $12.5 Million
Q1 2024 May 15, 2024	SELL	$10.83 - $16.49 $6.84 Million - $10.4 Million	-631,404 Reduced 14.29%	3,785,652 $59.7 Million
Q4 2023 Feb 14, 2024	BUY	$9.84 - $20.13 $16.9 Million - $34.5 Million	1,713,696 Added 63.39%	4,417,056 $66.9 Million
Q3 2023 Nov 14, 2023	SELL	$19.63 - $28.29 $8.82 Million - $12.7 Million	-449,554 Reduced 14.26%	2,703,360 $54.2 Million
Q2 2023 Aug 14, 2023	BUY	$17.41 - $30.05 $5.59 Million - $9.64 Million	320,891 Added 11.33%	3,152,914 $88.9 Million
Q1 2023 May 15, 2023	SELL	$16.14 - $24.94 $4.07 Million - $6.29 Million	-252,114 Reduced 8.17%	2,832,023 $48.7 Million
Q4 2022 Feb 14, 2023	BUY	$18.07 - $25.6 $4.23 Million - $5.99 Million	233,963 Added 8.21%	3,084,137 $62.1 Million
Q3 2022 Nov 15, 2022	SELL	$20.23 - $31.73 $5.45 Million - $8.55 Million	-269,560 Reduced 8.64%	2,850,174 $61.7 Million
Q2 2022 Aug 15, 2022	BUY	$17.91 - $52.25 $18.6 Million - $54.3 Million	1,039,294 Added 49.96%	3,119,734 $87.7 Million
Q1 2022 May 16, 2022	BUY	$41.58 - $80.89 $30.5 Million - $59.4 Million	734,024 Added 54.52%	2,080,440 $96 Million
Q4 2021 Feb 14, 2022	BUY	$66.92 - $84.79 $3.62 Million - $4.59 Million	54,153 Added 4.19%	1,346,416 $113 Million
Q3 2021 Nov 15, 2021	SELL	$46.83 - $73.5 $2.2 Million - $3.46 Million	-47,077 Reduced 3.51%	1,292,263 $86.1 Million
Q2 2021 Aug 16, 2021	SELL	$37.41 - $62.25 $4.86 Million - $8.08 Million	-129,851 Reduced 8.84%	1,339,340 $71.3 Million
Q1 2021 May 17, 2021	BUY	$35.69 - $52.72 $20.6 Million - $30.5 Million	577,682 Added 64.8%	1,469,191 $63.7 Million
Q4 2020 Feb 16, 2021	BUY	$31.71 - $57.97 $23.1 Million - $42.3 Million	729,915 Added 451.7%	891,509 $46.3 Million
Q3 2020 Nov 10, 2020	BUY	$27.03 - $47.97 $657,477 - $1.17 Million	24,324 Added 17.72%	161,594 $5.28 Million
Q2 2020 Aug 14, 2020	BUY	$23.2 - $54.8 $3.18 Million - $7.52 Million	137,270 New	137,270 $6.59 Million

Others Institutions Holding ZNTL

# of Institutions

142

Shares Held

67.9M

Call Options Held

48.5K

Put Options Held

89.6K

View Full List

About Zentalis Pharmaceuticals, Inc.

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $191M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

More about ZNTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Zentalis Pharmaceuticals, Inc. Transaction History